BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26012164)

  • 1. [Guidelines for diagnosis, therapy and follow up of Anderson-Fabry disease].
    Kes VB; Cesarik M; Zavoreo I; Butković SS; Kes P; Bašić-Jukić N; Rački S; Jakić M; Delić-Brkljačić D; Jukić Z; Trkanjec Z; Šerić V; Solter VV; Bielen I; Bašić S; Demarin V; ; ; ;
    Acta Med Croatica; 2014 Apr; 68(2):223-32. PubMed ID: 26012164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for diagnosis, therapy and follow up of Anderson-Fabry disease.
    Kes VB; Cesarik M; Zavoreo I; Soldo-Butković S; Kes P; Basić-Jukić N; Racki S; Jakić M; Delić-Brkljacić D; Jukić Z; Trkanjec Z; Serić V; Solter VV; Bielen I; Basić S; Demarin V; ; ; ;
    Acta Clin Croat; 2013 Sep; 52(3):395-405. PubMed ID: 24558776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anderson-Fabry disease: developments in diagnosis and treatment.
    Kes VB; Cesarik M; Zavoreo I; Madzar Z; Demarin V
    Acta Clin Croat; 2012 Sep; 51(3):411-7. PubMed ID: 23330407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The neurological manifestations of Fabry disease. A review].
    Firsov KV; Kotov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9):98-105. PubMed ID: 27735906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological complications of Anderson-Fabry disease.
    Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Arnao V; Licata G; Pinto A
    Curr Pharm Des; 2013; 19(33):6014-30. PubMed ID: 23448452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Musculoskeletal manifestations of Fabry disease: A retrospective study.
    Lidove O; Zeller V; Chicheportiche V; Meyssonnier V; Sené T; Godot S; Ziza JM
    Joint Bone Spine; 2016 Jul; 83(4):421-6. PubMed ID: 26697993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anderson-Fabry disease: developments in diagnosis and treatment.
    Mehta AB
    Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S66-74. PubMed ID: 20040315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anderson-Fabry disease].
    Kes P; Basić-Jukić N; Brunetta B; Jurić I
    Acta Med Croatica; 2006; 60(1):55-8. PubMed ID: 16802573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fabry disease: proposed guidelines from a French expert group for its diagnosis, treatment and follow-up].
    Lidove O; Bekri S; Goizet C; Khau Van Kien A; Aractingi S; Knebelmann B; Choukroun G; Tsimaratos M; Redonnet-Vernhet I; Lacombe D; Jaussaud R
    Presse Med; 2007; 36(7-8):1084-97. PubMed ID: 17276649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults.
    Ortiz A; Oliveira JP; Wanner C; Brenner BM; Waldek S; Warnock DG
    Nat Clin Pract Nephrol; 2008 Jun; 4(6):327-36. PubMed ID: 18431378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabry disease: focus on cardiac manifestations and molecular mechanisms.
    Perrot A; Osterziel KJ; Beck M; Dietz R; Kampmann C
    Herz; 2002 Nov; 27(7):699-702. PubMed ID: 12439642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fabry disease].
    Kantola I; Penttinen M; Nuutila P; Viikari J
    Duodecim; 2012; 128(7):729-39. PubMed ID: 22612023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hearing loss in patients with Fabry disease].
    Limberger A; Beck M; Delgado-Sanchez S; Keilmann A
    HNO; 2007 Mar; 55(3):185-9. PubMed ID: 17004069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice.
    Terryn W; Cochat P; Froissart R; Ortiz A; Pirson Y; Poppe B; Serra A; Van Biesen W; Vanholder R; Wanner C
    Nephrol Dial Transplant; 2013 Mar; 28(3):505-17. PubMed ID: 23234755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fabry disease--guidelines for diagnosis and management of adult patients].
    Merkler M; Pećin I; Simić I; Muacević-Katanec D; Sućur N; Reiner Z
    Lijec Vjesn; 2014; 136(5-6):133-5. PubMed ID: 25154181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroenterological complications of Anderson-Fabry disease.
    Buda P; Książyk J; Tylki-Szymanska A
    Curr Pharm Des; 2013; 19(33):6009-13. PubMed ID: 23448457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabry disease: recognition and management of cutaneous manifestations.
    Möhrenschlager M; Braun-Falco M; Ring J; Abeck D
    Am J Clin Dermatol; 2003; 4(3):189-96. PubMed ID: 12627994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular pathology and clinical manifestations of Fabry disease].
    Rákóczi E; Görögh S; Grubits J; Erdos M; Garzuly F; Hahn K; Bencsik K; Vécsei L; Trinn C; Kristóf E; Mogyorósy G; Tóth B; Maródi L
    Orv Hetil; 2007 Jun; 148(23):1087-94. PubMed ID: 17545117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabry's disease.
    Adam T; Alexandrescu L; Voinea F; Toringhibel M; Hâncu A
    Rom J Intern Med; 2006; 44(4):455-64. PubMed ID: 18386622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A boy with Fabry disease with the onset at the age of four].
    Liu YP; Huang Y; Wang Q; Wu TF; Ma YY; Li XY; Song JQ; Yang YL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):307-11. PubMed ID: 23591357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.